These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30417131)

  • 1. Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability.
    Lu Y; Maruyama J; Kuwata K; Fukuda H; Iwasa H; Arimoto-Matsuzaki K; Sugimura H; Hata Y
    Biochem Biophys Rep; 2018 Dec; 16():130-137. PubMed ID: 30417131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.
    Li L; Bellows CF
    Chin J Cancer Res; 2013 Apr; 25(2):134-42. PubMed ID: 23592893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doublecortin and CaM kinase-like-1 expression in pathological stage I non-small cell lung cancer.
    Tao H; Tanaka T; Okabe K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1449-1459. PubMed ID: 28382517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional implication of Dclk1 and Dclk1-expressing cells in cancer.
    Westphalen CB; Quante M; Wang TC
    Small GTPases; 2017 Jul; 8(3):164-171. PubMed ID: 27458755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulatory control of microtubule binding in doublecortin-like kinase 1.
    Agulto RL; Rogers MM; Tan TC; Ramkumar A; Downing AM; Bodin H; Castro J; Nowakowski DW; Ori-McKenney KM
    Elife; 2021 Jul; 10():. PubMed ID: 34310279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles.
    Lazer LM; Kesavan Y; Gor R; Ramachandran I; Pathak S; Narayan S; Anbalagan M; Ramalingam S
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112612. PubMed ID: 35738074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis.
    Carli ALE; Hardy JM; Hoblos H; Ernst M; Lucet IS; Buchert M
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCLK1 phosphorylates the microtubule-associated protein MAP7D1 to promote axon elongation in cortical neurons.
    Koizumi H; Fujioka H; Togashi K; Thompson J; Yates JR; Gleeson JG; Emoto K
    Dev Neurobiol; 2017 Apr; 77(4):493-510. PubMed ID: 27503845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.
    Kim JH; Park SY; Jeon SE; Choi JH; Lee CJ; Jang TY; Yun HJ; Lee Y; Kim P; Cho SH; Lee JS; Nam JS
    Theranostics; 2022; 12(12):5258-5271. PubMed ID: 35910805
    [No Abstract]   [Full Text] [Related]  

  • 12. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 Kinase.
    Weygant N; Ge Y; Qu D; Kaddis JS; Berry WL; May R; Chandrakesan P; Bannerman-Menson E; Vega KJ; Tomasek JJ; Bronze MS; An G; Houchen CW
    Cancer Res; 2016 Jul; 76(14):4090-9. PubMed ID: 27287716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress of DCLK1 Inhibitors as Cancer Therapeutics.
    Cheng L; Huang S; Chen L; Dong X; Zhang L; Wu C; Ye K; Shao F; Zhu Z; Thorne RF
    Curr Med Chem; 2022; 29(13):2261-2273. PubMed ID: 34254905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCLK1 and its oncogenic functions: A promising therapeutic target for cancers.
    Ye L; Liu B; Huang J; Zhao X; Wang Y; Xu Y; Wang S
    Life Sci; 2024 Jan; 336():122294. PubMed ID: 38007147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1.
    Patel O; Dai W; Mentzel M; Griffin MD; Serindoux J; Gay Y; Fischer S; Sterle S; Kropp A; Burns CJ; Ernst M; Buchert M; Lucet IS
    Structure; 2016 Sep; 24(9):1550-61. PubMed ID: 27545623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice.
    Tuy FP; Saillour Y; Kappeler C; Chelly J; Francis F
    Dev Neurosci; 2008; 30(1-3):171-86. PubMed ID: 18075264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DCLK1 autoinhibition and activation in tumorigenesis.
    Cheng L; Yang Z; Guo W; Wu C; Liang S; Tong A; Cao Z; Thorne RF; Yang SY; Yu Y; Chen Q
    Innovation (Camb); 2022 Jan; 3(1):100191. PubMed ID: 34977835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation.
    Pan P; Ji D; Li Z; Meng X
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2287990. PubMed ID: 38062554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.